Northrop Grumman Corporation
NOC
$587.66
-0.33%
Northrop Grumman Corporation is a premier global aerospace and defense technology company, providing advanced systems and products across aeronautics, defense, mission, and space segments. It is a top-tier prime contractor and a critical supplier to the U.S. Department of Defense and allied governments, distinguished by its role in high-profile programs like the B-21 Raider stealth bomber, the F-35 fuselage, and Global Hawk drones. The current investor narrative is dominated by the interplay of robust geopolitical-driven defense budget tailwinds, particularly from the Iran conflict and proposed massive U.S. military spending increases, against concerns over program-specific risks and potential volatility from political rhetoric regarding NATO and budget allocations.…
NOC
Northrop Grumman Corporation
$587.66
Related headlines
Investment Opinion: Should I buy NOC Today?
Rating & Thesis: Hold. NOC is a high-quality defense prime with strong fundamentals, but its premium valuation and near-term technical weakness suggest waiting for a better entry point or clearer resolution of budget allocation risks. This aligns with a neutral stance, as the implied upside from analyst EPS estimates is balanced by valuation concerns.
Supporting Evidence: The stock trades at a forward PE of 22.04x, which is at a premium to typical industrial/defense peers. While revenue growth is accelerating (9.6% YoY in Q4) and profitability is improving (net margin expanded 700+ bps in 2025), these positives appear largely priced in. The PEG ratio of 7.41 is exceptionally high, signaling expensive growth. Analyst EPS estimates imply a forward earnings yield of ~4.5%, which must be weighed against the 1.58% dividend yield and the stock's recent 8.22% monthly decline.
Risks & Conditions: The two biggest risks are valuation compression and political budget reallocation. This Hold rating would upgrade to a Buy if the stock corrects further toward the $600-$620 support zone, making the valuation more compelling, or if concrete budget details confirm robust funding for NOC's key programs. It would downgrade to a Sell if revenue growth decelerates below 5% or if the forward PE fails to hold support above 20x. Based on current data, the stock is fairly valued to slightly overvalued relative to its near-term growth trajectory, justifying a patient approach.
Sign up to view all
NOC 12-Month Price Forecast
The outlook is balanced with a slight skew to the base case. The company's operational performance is strong, but the stock's reaction function is now tied more to political budget outcomes than quarterly execution. The premium valuation provides little cushion for disappointment, making the near-term path dependent on clarifying the budget catalyst. The stance would upgrade to bullish on a conclusive budget win for NOC's programs or a further pullback to a more attractive valuation (~20x forward PE). It would turn bearish on a confirmed budget loss or a breakdown below key technical support near $650.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Northrop Grumman Corporation's 12-month outlook, with a consensus price target around $763.96 and implied upside of +30.0% versus the current price.
Average Target
$763.96
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$470 - $764
Analyst target range
Analyst coverage for Northrop Grumman is limited but appears to be institutionally followed, with 7 analysts providing estimates. The consensus leans bullish, as evidenced by recent institutional ratings from firms like UBS, Citigroup, B of A Securities, and RBC Capital maintaining "Buy" or "Outperform" ratings in January 2026. The average target price must be derived from estimates; the average estimated EPS for the forward period is $36.50, with a range from $35.77 to $37.40, indicating tight clustering and high conviction in near-term earnings projections. The target price range implied by the EPS estimates, when combined with the forward PE multiple, suggests a consensus view, but the exact average price target is not provided in the data. The high EPS estimate of $37.40 likely assumes flawless execution on key programs like the B-21 and continued budget tailwinds, while the low estimate of $35.77 may factor in potential cost overruns or budgetary pressures. The recent news highlights a bifurcated narrative: some analysts view proposed massive defense budgets as a major catalyst, while others flag NOC as a potential loser if spending prioritizes shipbuilding and missiles over stealth bombers, contributing to the uncertainty reflected in recent price volatility.
Bulls vs Bears: NOC Investment Factors
The bull case, supported by accelerating revenue growth, expanding margins, and a fortified backlog from geopolitical tailwinds, currently holds stronger evidence. However, the bear case presents significant near-term risks, primarily centered on valuation and political uncertainty. The single most important tension in the investment debate is whether the proposed massive defense budget increases will flow proportionally to NOC's key programs (like the B-21) or be reallocated to other priorities, as some analysts warn. The resolution of this budget allocation uncertainty will be the primary driver of whether the stock's premium multiple is justified or contracts.
Bullish
- Strong Revenue Growth & Acceleration: Q4 2025 revenue grew 9.6% YoY to $11.71B, accelerating from prior quarters and showing a consistent sequential uptrend throughout 2025. This solid growth is underpinned by a favorable defense budget environment and strong program execution.
- Robust Profitability & Margin Expansion: Net margin expanded significantly from 5.1% in Q1 2025 to 12.2% in Q4 2025, demonstrating strong operating leverage. The company generated $3.31B in TTM free cash flow, funding substantial shareholder returns via dividends and buybacks.
- Prime Contractor on Key Long-Term Programs: NOC is the prime contractor for the next-generation B-21 Raider stealth bomber and a critical supplier for the F-35, securing a multi-decade revenue stream. Analyst consensus points to a proposed $1.5T military budget as a major catalyst for these high-profile programs.
- Analyst Conviction in Near-Term Earnings: Analyst EPS estimates for the forward period are tightly clustered between $35.77 and $37.40, with an average of $36.50, indicating high conviction. Recent institutional ratings from major firms like UBS and B of A Securities maintain bullish 'Buy' or 'Outperform' stances.
Bearish
- Elevated Valuation Leaves Little Margin for Error: The forward PE of 22.04x and a PEG ratio of 7.41 suggest the market is pricing in significant long-term growth. This premium valuation, coupled with a trailing PE of 19.57x near its historical high end, makes the stock susceptible to multiple compression if growth expectations falter.
- Recent Sharp Momentum Reversal & Pullback: The stock is down 8.22% over the past month and has retreated to ~86% of its 52-week range from a high of $774. This technical breakdown signals profit-taking and a potential correction after an overextended rally, introducing near-term volatility risk.
- Political & Budget Allocation Risks: Recent news highlights NOC as a potential 'loser' if proposed massive defense spending prioritizes shipbuilding and missiles over stealth bombers. Furthermore, political rhetoric regarding NATO introduces headline volatility and long-term strategic uncertainty for major contractors.
- Leveraged Balance Sheet: A debt-to-equity ratio of 1.18 indicates a leveraged capital structure. While manageable given strong cash flows, it reduces financial flexibility and increases sensitivity to rising interest rates or a downturn in defense spending.
NOC Technical Analysis
The stock is in a sustained long-term uptrend but is currently experiencing a significant near-term pullback from recent highs. The 1-year price change of +23.11% confirms the underlying bullish trend, yet the current price of $665.26 sits at approximately 86% of its 52-week range ($450.13 to $774.00), indicating it has retreated meaningfully from its peak and is now in a consolidation phase. This positioning suggests the momentum-driven rally may have been overextended, and the stock is now testing for support after a period of profit-taking. Recent momentum has turned sharply negative, diverging from the longer-term uptrend and signaling a potential correction. The 1-month price change is -8.22%, and the 3-month change is -0.25%, indicating a clear deceleration and reversal from the powerful rally seen in January and February 2026. This divergence, where short-term momentum contradicts the positive 1-year trend, often signals a healthy pullback within a bull market but requires monitoring for a breakdown of key support levels to confirm it is not the start of a deeper trend reversal. Key technical support is anchored at the 52-week low of $450.13, though more immediate support lies in the $650-$670 zone where the stock has recently traded. Resistance is clearly defined at the 52-week high of $774.00. A breakout above $774 would signal a resumption of the primary uptrend, while a sustained breakdown below the recent lows near $665 could open a path toward the $600 level. The stock's beta of 0.046, indicating extreme low correlation and volatility relative to the SPY, is anomalous for a defense stock and may reflect data issues; typically, defense primes have betas around 0.8-1.0, implying market-like volatility.
Beta
0.05
0.05x market volatility
Max Drawdown
-23.5%
Largest decline past year
52-Week Range
$453-$774
Price range past year
Annual Return
+24.3%
Cumulative gain past year
| Period | NOC Return | S&P 500 |
|---|---|---|
| 1m | -13.9% | +8.5% |
| 3m | -12.7% | +2.8% |
| 6m | -3.0% | +4.6% |
| 1y | +24.3% | +32.3% |
| ytd | +0.3% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NOC Fundamental Analysis
Revenue growth is solid and accelerating, supported by a favorable defense budget environment. The most recent quarterly revenue (Q4 2025) was $11.71 billion, representing a 9.6% year-over-year growth rate. This marks an acceleration from the prior-year Q4 revenue of $10.69 billion, and the sequential quarterly revenue trend through 2025 (Q1: $9.47B, Q2: $10.35B, Q3: $10.42B, Q4: $11.71B) shows consistent quarterly expansion, underpinning a robust growth trajectory. Segment data from a recent period shows Aeronautics Systems ($3.92B) and Mission Systems ($3.45B) as the largest contributors, with all four segments generating multi-billion dollar revenue streams. Profitability is strong with expanding margins, reflecting operating leverage and disciplined execution. The company reported net income of $1.43 billion for Q4 2025, with a net margin of 12.2%. The gross margin for the quarter was 19.6%, and the operating margin was 8.9%. More importantly, profitability has improved sequentially through 2025; for instance, the Q1 2025 net margin was only 5.1%, which expanded to 10.6% in Q3 and 12.2% in Q4, demonstrating significant margin recovery and expansion as the year progressed, a positive sign for earnings quality. The balance sheet is leveraged but cash flow generation is robust, supporting shareholder returns and internal investment. The debt-to-equity ratio is 1.18, indicating a leveraged but manageable capital structure typical for defense contractors. Crucially, the company generated strong free cash flow, with TTM free cash flow at $3.31 billion. This substantial cash generation, evidenced by Q4 2025 operating cash flow of $3.90 billion and free cash flow of $3.24 billion, funds dividends ($329M paid in Q4) and share repurchases ($456M in Q4) while maintaining financial flexibility. The current ratio of 1.09 suggests adequate short-term liquidity.
Quarterly Revenue
$11.7B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.19%
Latest Quarter
Free Cash Flow
$3.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NOC Overvalued?
Given the company's consistent profitability, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing twelve-month PE ratio is 19.57x, while the forward PE is 22.04x. The higher forward multiple suggests the market is pricing in expectations for future earnings growth, aligning with the visible revenue acceleration and margin expansion trends observed in the recent financials. Compared to sector averages implied by the provided data, Northrop Grumman's valuation appears to command a premium, justified by its prime contractor status and exposure to next-generation programs like the B-21. The trailing PE of 19.57x and forward PE of 22.04x, alongside a Price-to-Sales ratio of 1.95 and EV/EBITDA of 13.49, position it as a higher-quality, growth-oriented name within the defense sector. The PEG ratio of 7.41, however, is elevated and suggests the market is already pricing in significant long-term growth, leaving less margin for error. Historically, the stock's current trailing PE of 19.57x sits above its own historical range observed in the data, which has fluctuated significantly from negative values during unusual quarters to highs above 38x. The current multiple is not at the peak but is towards the higher end of the normal spectrum, indicating the market is pricing in optimistic expectations about sustained defense budget growth and program execution. This leaves the stock susceptible to multiple compression if growth expectations are not met or if geopolitical tailwinds subside.
PE
19.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -33x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Northrop Grumman's primary financial risk stems from its leveraged balance sheet, with a debt-to-equity ratio of 1.18. While robust TTM free cash flow of $3.31B provides ample coverage, a sustained period of rising interest rates could pressure net income. Operationally, the company faces program-specific execution risks on marquee projects like the B-21, where cost overruns could compress the recently expanded net margins, which improved from 5.1% to 12.2% through 2025. Revenue, while diversified across four segments, remains heavily concentrated in U.S. government contracts, creating dependency on political budget cycles.
Market & Competitive Risks: The stock's valuation presents a clear market risk. Trading at a forward PE of 22.04x and a PEG of 7.41, NOC commands a significant growth premium. Any disappointment in earnings growth or a shift in sector sentiment away from defense primes could trigger substantial multiple compression. Competitively, while NOC is a prime contractor, budget reallocation risks highlighted in recent news could see funding diverted to peers in shipbuilding or missiles. The stock's anomalous beta of 0.046 is likely erroneous; a more typical beta near 1.0 would imply market-like volatility and correlation to broader risk-off moves.
Worst-Case Scenario: The worst-case scenario involves a combination of political headwinds and execution missteps. A U.S. budget compromise that significantly underfunds next-generation aircraft programs, coupled with a major cost overrun on the B-21, could trigger analyst downgrades and a derating of the premium multiple. This could see the stock re-test its 52-week low of $450.13, representing a potential downside of approximately -32% from the current price of $665.26. A more realistic severe bear case might align with a reversion to its lower historical PE range, implying a downside risk in the -20% to -25% range.
FAQ
The key risks are: 1) Valuation Risk: High multiples (PEG 7.41) make the stock vulnerable to de-rating if growth slows. 2) Political/Budget Risk: Proposed defense spending may not materialize as expected or may be reallocated away from NOC's key programs like the B-21, as noted in recent analyst commentary. 3) Execution Risk: Complex programs like the B-21 are prone to cost overruns and delays, which could pressure the expanding 12.2% net margin. 4) Financial Risk: A debt-to-equity ratio of 1.18 introduces leverage, though it is currently well-supported by strong cash flow.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $700 and $774, driven by meeting analyst EPS estimates of $36.50 and stable valuation multiples. The Bull Case (30% probability) targets $774 to $850, requiring a budget tailwind and flawless execution. The Bear Case (20% probability) warns of a drop to $550-$650 on budget disappointments and multiple compression. The most likely outcome is the Base Case, assuming the geopolitical spending narrative holds but the stock's premium multiple does not expand further from current levels.
NOC appears fairly valued to slightly overvalued based on traditional metrics. Its forward PE of 22.04x is at a premium to many industrial peers, justified by its prime contractor status and exposure to long-cycle programs. However, the elevated PEG ratio of 7.41 suggests the market is pricing in very optimistic long-term growth, leaving little room for error. Compared to its own historical PE range, the current multiple is toward the higher end. The valuation implies the market expects continued high-single-digit revenue growth and sustained margin expansion; any deviation could lead to multiple compression.
NOC is a good stock for investors with a long-term horizon and a belief in sustained U.S. defense budget growth, but timing is crucial. At its current price of $665.26 and forward PE of 22x, the stock is fairly valued, pricing in much of its near-term growth. The 1.58% dividend yield and strong buyback program add to total return potential. However, given the recent 8% pullback and unresolved budget allocation risks, it may be prudent for new investors to wait for a clearer positive catalyst or a deeper pullback toward the $620-$640 range to improve the risk/reward profile.
NOC is predominantly suitable for a long-term investment horizon of 3-5 years. Its business model is based on multi-year government contracts and long-cycle programs like the B-21, the benefits of which will accrue over decades. The stock's low historical beta (though potentially anomalous) and 1.58% dividend yield also support a buy-and-hold strategy. Short-term traders face significant headline volatility from political budget rhetoric and the stock's current technical weakness following an 8% monthly decline. A minimum holding period of 12-18 months is recommended to navigate near-term noise and capture the underlying programmatic growth.
